Skip to main content
Journal ArticleOPEN ACCESS

Arsenic trioxide for the treatment of acute promyelocytic leukaemia

Cochrane Database of Systematic Reviews (2016) 2016(12)
DOI: 10.1002/14651858.CD008425.pub2
1Citations
Citations of this article
13Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To assess the role of arsenic trioxide (ATO) for treating patients with acute promyelocytic leukaemia in comparison with regimens without ATO.

Cite

CITATION STYLE

APA

Xu, S., Chen, J., Liu, J. P., Xia, Y., Li, X., & Tan, Y. (2016). Arsenic trioxide for the treatment of acute promyelocytic leukaemia. Cochrane Database of Systematic Reviews, 2016(12). https://doi.org/10.1002/14651858.CD008425.pub2

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free